POSNER BRIAN M 4
4 · Cellectar Biosciences, Inc. · Filed Apr 6, 2018
Insider Transaction Report
Form 4
POSNER BRIAN M
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2018-04-06+80,000→ 80,000 totalExercise: $1.17Exp: 2028-04-06→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Options vest in equal annual increments over a period of three years from the date of grant.